SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-290972
Filing Date
2023-12-08
Accepted
2023-12-07 21:26:59
Documents
17
Period of Report
2023-12-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d60594d8k.htm   iXBRL 8-K 35496
2 EX-1.1 d60594dex11.htm EX-1.1 259042
3 EX-5.1 d60594dex51.htm EX-5.1 53450
4 EX-99.1 d60594dex991.htm EX-99.1 8470
8 GRAPHIC g60594dsp12.jpg GRAPHIC 4433
9 GRAPHIC g60594g1207191924528.jpg GRAPHIC 3259
  Complete submission text file 0001193125-23-290972.txt   575490

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA wve-20231206.xsd EX-101.SCH 2874
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20231206_lab.xml EX-101.LAB 17926
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20231206_pre.xml EX-101.PRE 11254
11 EXTRACTED XBRL INSTANCE DOCUMENT d60594d8k_htm.xml XML 3326
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 231473806
SIC: 2834 Pharmaceutical Preparations